Showing results (141-150 of 1,015) with videos related to

Sort By:
Pageof 102
Parkinsonism & Related Disorders|December 28, 2020
Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Robert A Hauser, Leonid Zeitlin, Stanley Fisher, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 17, 2007
Muscle-epidermis interactions affect exoskeleton patterning in Caenorhabditis elegansLimor Broday, Craig A Hauser, Irina Kolotuev, et al.
Current Neurology and Neuroscience Reports|July 10, 2007
Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatmentTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
Methods in Enzymology|January 1, 1994
Transcriptional activation analysis of oncogene functionC A Hauser, C J Der, A D Cox
Neurology|May 1, 1989
Psychologic and social adjustment to epilepsy in Rochester, MinnesotaJ A Trostle, W A Hauser, F W Sharbrough
Nucleic Acids Research|June 11, 1985
The nucleotide sequence of the ilvBN operon of Escherichia coli: sequence homologies of the acetohydroxy acid synthase isozymesR C Wek, C A Hauser, G W Hatfield
The American Journal of Physiology|February 12, 1998
MDR1 in taste buds of rat vallate papilla: functional, immunohistochemical, and biochemical evidenceI Jakob, I A Hauser, F Thévenod, et al.
Clinical Parkinsonism & Related Disorders|June 9, 2025
Sedation and sleep safety of pimavanserin for Parkinsons's disease psychosis: Review and exploratory analysis of clinical study dataAna Berrio, Lambros Chrones, Victor Abler, et al.
Schweizerische Medizinische Wochenschrift|August 29, 1981
[Recurring, histologically confirmed Moschcowitz syndrome during pregnancy]J E Tapia, G A Hauser, G F Riedler
Nature Reviews. Drug Discovery|October 13, 2018
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugsDelphine Charvin, Rossella Medori, Robert A Hauser, et al.
Pageof 102